Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Albiglutide is a new medication that is injected once a week and acts as a glucagon-like peptide-1 receptor agonist to treat type 2 diabetesm(1).
Albiglutide, a once-weekly GLP-1 receptor agonist, received both FDA and EMA approval specifically for the treatment of Type 2 Diabetes (T2D) in adults. In the context of Albiglutide & Type 2 Diabetes (T2D), the US FDA approved albiglutide on April 15, 2014, for improving glycemic control in t…